Author:
Chang Gee-Chen,Yu Chang-Tze Ricky,Tsai Ching-Hwa,Tsai Jia-Rong,Chen Jen-Chi,Wu Chun-Chi,Wu Wen-Jun,Hsu Shih-Lan
Reference69 articles.
1. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition;Albanell;J. Clin. Oncol.,2002
2. -linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells;Amantana;Mol. Cancer Ther.,2004
3. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma;Ambrosini;Nat. Med.,1997
4. Gefitinib, a selective EGF receptor tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells;Ariyama;J. Cell Biochem.,2006
5. The schedule-dependent enhanced cytotoxic activity of 7-ethyl-10-hydroxy-camptothecin (SN-38) in combination with Gefitinib (Iressa, ZD1839);Azzariti;Biochem. Pharmacol.,2004
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献